1. China Stocks

  2. •

    Technology services

  3. •

    Packaged software
Genimous Technology Co., Ltd. Class A

Genimous Technology Co., Ltd. Class A

SSZSE:000676
6.39
CNY
+0.30
(+4.93%)
0.19EPS
31.44P/E
6.44BMarket Cap
Genimous Technology Co., Ltd. Class A
SZSE:000676
(Shenzhen Stock Exchange)

Recent

price

6.39

P/E

ratio

31.44

div

yld

0.10%

ROIC.AI

2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
CNY
1.92
1.76
1.18
1.08
0.91
0.77
2.62
5.08
6.11
8.66
8.5
4.58
2.14
2.31
2.7
3.29
3.38
Revenue per Share
0.03
-0.19
-0.34
0.05
-0.17
0.01
0.35
0.42
0.57
0.49
-2.3
0.11
-0.29
0.25
0.17
0.11
0.16
Basic EPS, GAAP
-0.15
-0.04
-0.1
0.05
0.15
0.07
0.01
-0.05
0.22
0.09
-0.18
0.06
0.6
-0.21
0.01
-0.08
- -
Free Cash Flow per Basic Share
0.04
0.06
0.06
0.05
0.05
0.03
- -
0.01
0.04
0.03
0.05
0.02
0.01
- -
- -
- -
0.01
Dividend per Share
0.95
0.76
0.42
0.51
0.35
0.35
3.67
4.02
4.67
5.03
2.79
3.01
2.81
3.08
3.29
3.39
3.42
Book Value per Share
0.78
0.6
0.3
0.4
0.23
0.33
1.29
1.77
2.37
2.86
2.25
2.4
2.47
2.74
2.99
3.11
3.15
Tangible Book Value per Share
409
409
409
409
409
410
903
1,256
1,255
1,255
1,268
1,276
1,276
1,268
1,257
1,253
1,253
Basic Weighted Avg Shares
784
720
483
440
373
318
2,364
6,375
7,674
10,874
10,778
5,844
2,729
2,929
3,390
4,119
4,239
Sales/Revenue/Turnover
7.71
-0.33
-10.93
4.52
-7.19
-11.11
12.38
8.18
10.45
4.67
-1
5.61
8.79
7.38
7.75
7.1
6.72
Operating Margin (%)
23
21
25
20
20
16
33
67
58
58
56
48
37
32
27
27
- -
Depreciation Expense
12
-79
-138
21
-69
4
316
527
713
620
-2,916
135
-368
322
213
142
204
Net Income, GAAP
24.62
- -
- -
27.07
- -
- -
12.64
3.75
7.92
8.53
- -
- -
- -
2.34
- -
- -
3.73
Effective Tax Rate (%)
1.51
-11.02
-28.49
4.78
-18.38
1.1
13.37
8.27
9.3
5.7
-27.06
2.32
-13.49
11
6.27
3.44
4.8
Profit Margin (%)
143
49
-94
-21
-90
43
2,160
2,421
2,425
2,456
2,033
1,870
1,999
2,369
2,740
2,895
2,963
Working Capital
12
2
2
16
15
1
1
98
- -
- -
200
27
9
24
15
4
8
LT Debt
478
360
201
232
150
146
4,610
5,055
5,863
6,655
3,668
3,802
3,561
3,991
4,292
4,453
4,480
Total Equity
2.87
- -
- -
-3.74
- -
- -
11.94
10.06
11.71
8.83
- -
- -
- -
11.21
- -
- -
5.26
Return on Invested Capital (%)
1.78
- -
- -
8.01
- -
- -
12.71
10.52
12.13
9.56
- -
- -
- -
6.31
- -
- -
3.76
Return on Capital (%)
3.21
-22.75
-57.1
10.98
-38.91
2.44
13.3
10.92
13.07
9.89
-56.24
3.59
-9.91
8.57
5.25
3.36
4.79
Return on Common Equity (%)

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
334
361
319
LT Borrowings
- -
- -
- -
LT Finance Leases
4
- -
8
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,260
1,260
1,260
Market Capitalization
10,872
9,574
6,438

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
3,592
3,577
3,668
Cash, Cash Equivalents & STI
1,537
1,509
1,611
Accounts Receivable, Net
1,159
1,172
1,170
Inventories
19
24
22
Total Current Liabilities
697
657
705
Payables & Accruals
- -
- -
- -
ST Debt
334
361
319
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
308.12%
4.14%
3.77%
Free Cash Flow
-206.56%
-32.3%
-643.64%
Net Income, GAAP
770.94%
-146.34%
-33.42%
Sales/Revenue/Turnover
82.08%
-10.9%
21.53%
Total Cash Common Dividend
31.38%
-31.18%
17.79%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
755
721
896
1,018
3,390
2025
1,110
1,055
- -
1,012
4,119
2026
1,046
1,127
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.05
0.04
0.04
0.05
0.17
2025
0.04
0.03
- -
0.02
0.11
2026
0.04
0.08
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -
Similar Companies
Microsoft Corporation (NASDAQ:MSFT)
Palantir Technologies Inc. (NASDAQ:PLTR)
Nebius Group N.V. (NASDAQ:NBIS)
Oracle Corporation (NYSE:ORCL)
CoreWeave, Inc. (NASDAQ:CRWV)
ServiceNow, Inc. (NYSE:NOW)
Business
Genimous Technology Co., Ltd. engages primarily in the research, development, manufacture, and sale of genetic testing products and services. The company's main product lines include high-throughput genetic sequencing platforms; gene chip technology; whole genome sequencing services; prenatal and reproductive genetic testing; precision medicine solutions; and personalized genetic health risk assessments. Genimous also provides bioinformatics analysis, genetic data interpretation, and consulting services targeted at hospitals, research institutions, and healthcare providers. The company serves a broad geographic market including China, with expanding operations in Asia and emerging global markets. Founded in 2010, Genimous Technology is headquartered in Shenzhen, China. In the past 1-2 years, Genimous Technology has made significant strategic advancements including forging partnerships with leading healthcare and technology firms to enhance its genetic data analytic capabilities and expand its service offerings. The company has introduced new prenatal genetic screening products leveraging advanced AI algorithms for higher accuracy and broader applicability. Additionally, Genimous has engaged in several funding rounds aimed at scaling its production capacity and accelerating research and development activities. These expansions reflect the company's strategic focus on precision medicine and genetic diagnostics growth sectors. There have been no recent name changes or major reorganizations reported, but the company continues to broaden its service portfolio with innovative genetic solutions to maintain competitive edge in the biotechnology industry.